Analysis of molecular and clinical markers of resistance to bacillus of Calmette-Guérin immunotherapy in patients with urothelial non-muscle invasive bladder cancer

Minerva Urol Nephrol. 2022 Oct;74(5):642-646. doi: 10.23736/S2724-6051.22.04959-X.
No abstract available

MeSH terms

  • Bacillus*
  • Biomarkers
  • Carcinoma, Transitional Cell* / drug therapy
  • Humans
  • Immunotherapy / adverse effects
  • Urinary Bladder Neoplasms* / drug therapy
  • Urologic Neoplasms*

Substances

  • Biomarkers